APA (7th ed.) Citation

Noh, Y. S., Yoon, S., Kim, S. R., Lee, K., & Jang, I. (2019). A safety, pharmacokinetic, pharmacogenomic and population pharmacokinetic analysis of the third‐generation EGFR TKI, olmutinib (HM61713), after single oral administration in healthy volunteers. Basic & clinical pharmacology & toxicology, 125(4), 370-381. https://doi.org/10.1111/bcpt.13262

Chicago Style (17th ed.) Citation

Noh, Young Su, Seonghae Yoon, Suk Ran Kim, Kyung‐Tae Lee, and In‐Jin Jang. "A Safety, Pharmacokinetic, Pharmacogenomic and Population Pharmacokinetic Analysis of the Third‐generation EGFR TKI, Olmutinib (HM61713), After Single Oral Administration in Healthy Volunteers." Basic & Clinical Pharmacology & Toxicology 125, no. 4 (2019): 370-381. https://doi.org/10.1111/bcpt.13262.

MLA (9th ed.) Citation

Noh, Young Su, et al. "A Safety, Pharmacokinetic, Pharmacogenomic and Population Pharmacokinetic Analysis of the Third‐generation EGFR TKI, Olmutinib (HM61713), After Single Oral Administration in Healthy Volunteers." Basic & Clinical Pharmacology & Toxicology, vol. 125, no. 4, 2019, pp. 370-381, https://doi.org/10.1111/bcpt.13262.